Cargando…
Mesenchymal Stem Cells Repress Th17 Molecular Program through the PD-1 Pathway
MSC display potent suppressive properties initially described a decade ago. More recently, MSC suppressive activities on T-cell effector pathways have been investigated. MSC modulate CD4 differentiation through different mechanisms depending on culture conditions and display disparate activities on...
Autores principales: | Luz-Crawford, Patricia, Noël, Danièle, Fernandez, Ximena, Khoury, Maroun, Figueroa, Fernando, Carrión, Flavio, Jorgensen, Christian, Djouad, Farida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444478/ https://www.ncbi.nlm.nih.gov/pubmed/23028899 http://dx.doi.org/10.1371/journal.pone.0045272 |
Ejemplares similares
-
Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway
por: Luz-Crawford, Patricia, et al.
Publicado: (2012) -
Mesenchymal stem cells generate a CD4(+)CD25(+)Foxp3(+) regulatory T cell population during the differentiation process of Th1 and Th17 cells
por: Luz-Crawford, Patricia, et al.
Publicado: (2013) -
Mesenchymal stem cell repression of Th17 cells is triggered by mitochondrial transfer
por: Luz-Crawford, Patricia, et al.
Publicado: (2019) -
Time-dependent LPS exposure commands MSC immunoplasticity through TLR4 activation leading to opposite therapeutic outcome in EAE
por: Kurte, Mónica, et al.
Publicado: (2020) -
Mechanisms behind the Immunoregulatory Dialogue between Mesenchymal Stem Cells and Th17 Cells
por: Terraza-Aguirre, Claudia, et al.
Publicado: (2020)